BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 22110662)

  • 1. Enhancement of canonical Wnt/β-catenin signaling activity by HCV core protein promotes cell growth of hepatocellular carcinoma cells.
    Liu J; Ding X; Tang J; Cao Y; Hu P; Zhou F; Shan X; Cai X; Chen Q; Ling N; Zhang B; Bi Y; Chen K; Ren H; Huang A; He TC; Tang N
    PLoS One; 2011; 6(11):e27496. PubMed ID: 22110662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus core protein activates Wnt/β-catenin signaling through multiple regulation of upstream molecules in the SMMC-7721 cell line.
    Liu J; Wang Z; Tang J; Tang R; Shan X; Zhang W; Chen Q; Zhou F; Chen K; Huang A; Tang N
    Arch Virol; 2011 Jun; 156(6):1013-23. PubMed ID: 21340743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hepatitis C virus core protein and nonstructural protein 4B on the Wnt/β-catenin pathway.
    Jiang XH; Xie YT; Cai YP; Ren J; Ma T
    BMC Microbiol; 2017 May; 17(1):124. PubMed ID: 28545480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of lemur tyrosine kinase 2 restricts the proliferation and invasion of hepatocellular carcinoma through modulation of GSK-3β/Wnt/β-catenin signaling.
    Zhao G; Song Y; Dong L; Shi H; Li H; Yang L; Wang J
    Biochem Biophys Res Commun; 2019 Oct; 517(4):722-728. PubMed ID: 31395338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
    Lu WJ; Chua MS; Wei W; So SK
    Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis.
    Park CY; Choi SH; Kang SM; Kang JI; Ahn BY; Kim H; Jung G; Choi KY; Hwang SB
    J Hepatol; 2009 Nov; 51(5):853-64. PubMed ID: 19726098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
    Usongo M; Li X; Farookhi R
    Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
    Chen Z; Tang J; Cai X; Huang Y; Gao Q; Liang L; Tian L; Yang Y; Zheng Y; Hu Y; Tang N
    Cancer Sci; 2016 Oct; 107(10):1380-1389. PubMed ID: 27420729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma.
    Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL
    BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.
    Liu Y; Ye X; Zhang JB; Ouyang H; Shen Z; Wu Y; Wang W; Wu J; Tao S; Yang X; Qiao K; Zhang J; Liu J; Fu Q; Xie Y
    Oncogene; 2015 Oct; 34(44):5524-35. PubMed ID: 25684142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zanthoxylum avicennae extract enhances GSK-3β to attenuate β-catenin via phosphatase 2A to block metastatic effects of HA22T cells and hepatocellular carcinoma xenografted nude mice.
    Wu HC; Lay IS; Shibu MA; Ho TJ; Cheng SM; Lin CH; Dung TD; Jeng LB; Viswanadha VP; Huang CY
    Environ Toxicol; 2017 Sep; 32(9):2133-2143. PubMed ID: 28548306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.
    Thompson MD; Dar MJ; Monga SP
    J Hepatol; 2011 Mar; 54(3):506-12. PubMed ID: 21093092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinoma.
    Mahmoudvand S; Shokri S; Taherkhani R; Farshadpour F
    World J Gastroenterol; 2019 Jan; 25(1):42-58. PubMed ID: 30643357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the Wnt/β-catenin pathway by hepatitis C virus recombinants expressing core from various genotypes.
    Aicher S; Kakkanas A; Cohen L; Blumen B; Oprisan G; Njouom R; Meurs EF; Mavromara P; Martin A
    Sci Rep; 2018 Jul; 8(1):11185. PubMed ID: 30046100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
    Fan W; Du F; Liu X
    Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting ER stress/PKA/GSK-3β/β-catenin pathway as a potential novel strategy for hepatitis C virus-infected patients.
    Lin D; Chen Y; Koksal AR; Dash S; Aydin Y
    Cell Commun Signal; 2023 May; 21(1):102. PubMed ID: 37158967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase.
    Yu Z; Feng H; Sun X; Zhuo Y; Li M; Zhou Z; Huang L; Jiang Y; Zhu X; Zhang X; Le F; Zheng C; Cheng AS; Gao Y
    Sci Rep; 2018 Mar; 8(1):3891. PubMed ID: 29497076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K; Han C; Dai Y; Shen M; Wu T
    Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.